Head-to-head · Cost-Efficiency Index
Invigor Medical vs Ivim Health
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Invigor Medical
Value shoppers who want competitive pricing on both molecules plus a wider wellness/hormone program on one account.
Visit Invigor MedicalIvim Health
Cost-first shoppers who want a compounded GLP-1 quoted with the programme charge folded in rather than added at checkout.
Visit Ivim HealthThe verdict
Invigor Medical takes it, leading the Cost-Efficiency Index 88 to 57. Solid mid-market cost on both molecules from an established operator — good value if you also want a broader metabolic and hormone catalog. Ivim Health still earns a C — Cost-first shoppers who want a compounded GLP-1 quoted with the programme charge folded in rather than added at checkout.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the board). See how it stacks up: CoreAge Rx vs Invigor Medical.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Invigor Medical | Ivim Health |
|---|---|---|
| Cost-Efficiency Index | 88/100 | 57/100 |
| Semaglutide / mo | $199/mo | $149/mo (starting dose, medication and programme fee, compounded) |
| Tirzepatide / mo | $339/mo | $224/mo (starting dose, medication and programme fee, compounded) |
| Semaglutide / yr (modeled) | $2,388 | $1,788 |
| Tirzepatide / yr (modeled) | $4,068 | $2,688 |
| Coverage | Not disclosed | Coverage not published |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Compounded only |
| Rank on the board | #8 | #272 |
Invigor Medical
88/100Where the value is
- Competitive mid-market pricing on both semaglutide and tirzepatide
- Long-running operator with a broad catalog that can consolidate spend
- Both molecules published up front for easy cost modeling
The tradeoffs
- Does not publish an explicit states-served list, so access is a variable in the model
- Compounded only
Ivim Health
57/100Where the value is
- Both molecules are priced on one page, each quoted as medication and programme charge included rather than as a bare drug price
- A six-month commitment brings tirzepatide down to $133/mo, and the term is published rather than hidden
- The first month of the membership is free
The tradeoffs
- A $75/mo membership is marketed as a separate product, and whether it is charged on top of the $149 medication rate is not stated anywhere we could find
- The $133/mo tirzepatide rate advertised on the homepage requires a six-month commitment; the month-to-month rate is $224
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.